Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis
European Journal of Heart Failure · 01.02.2024 · 26 (2) · 511-520
DOI: 10.1002/ejhf.3073 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 09.11.2023. Verfasst von Sander Trenson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Heart Failure, Defibrillators, Implantable. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Aim
Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. However, data on long-term outcome after upgrade to CRT are scarce. Methods and results This international, multicentre retrospective registry included 2275 patients who underwent a de novo or upgrade CRT implantation with a mean follow-up of 3.6 ± 2.7 years. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. Multivariable Cox regression and propensity score matching (PSM) analyses were performed. Patients who underwent CRT upgrade (n = 605, 26.6%) were less likely female (19.7% vs. 28.8%, p < 0.001), more often had ischeemic cardiomyopathy (49.8% vs. 40.2%, p < 0.001), and had worse renal function (median estimated glomerular filtration rate 50.3 ml/min/1.73 m2 [35.8–69.5] vs. 59.9 ml/min/1.73 m2 [43.0–76.5], p < 0.001). The incidence rate of the composite endpoint was 10.8%/year after CRT upgrade versus 7.1%/year for de novo implantations (p < 0.001). PSM for the primary endpoint resulted in 488 pairs. After propensity score matching, upgrade to CRT was associated with a higher chance to reach the composite endpoint (multivariable hazard ratio [HR] 1.35, 95% confidence interval [CI] 1.08–1.70), for both upgrade from pacemaker (multivariable HR 1.33, 95% CI 1.03–1.70) and implantable cardioverter-defibrillator (ICD) (multivariable HR 1.40, 95% CI 1.01–1.95). PSM for the secondary endpoint resulted in 277 pairs. After PSM, upgrade to CRT was associated with a higher chance for heart failure admission (HR 1.74, 95% CI 1.26–2.41).
Conclusion
In this retrospective analysis, the outcome of patients who underwent upgrades to CRT differed significantly from patients who underwent de novo CRT implantation, particularly for upgrades from ICD. Importantly, this difference in outcome does not imply a causal relation between therapy and outcome but rather a difference between two different patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
- Department of Cardiology, Sint-Jan Hospital Bruges, Bruges, Belgium.
- Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
- Department of Cardiology, University Hospitals Leuven, Leuven, Belgium.
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
- Department of Life Sciences, Hasselt University, Hasselt, Belgium.
ORCID-Profile: Bert Vandenberk
Zitieren
APA
Trenson, S., Voros, G., Martens, P., Ingelaere, S., Betschart, P., Voigt, J. U., Dupont, M., Breitenstein, A., Steffel, J., Willems, R., Ruschitzka, F., Mullens, W., Winnik, S., & Vandenberk, B. (2024). Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis. European Journal of Heart Failure, 26(2), 511-520. https://doi.org/10.1002/ejhf.3073
Vancouver
Trenson S, Voros G, Martens P, Ingelaere S, Betschart P, Voigt JU, et al. Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis. European Journal of Heart Failure. 2024;26(2):511-520. doi:10.1002/ejhf.3073
BibTeX
@article{Trenson2024,
author = {Trenson, Sander and Voros, Gabor and Martens, Pieter and Ingelaere, Sebastian and Betschart, Pascal and Voigt, Jens-Uwe and Dupont, Matthias and Breitenstein, Alexander and Steffel, Jan and Willems, Rik and Ruschitzka, Frank and Mullens, Wilfried and Winnik, Stephan and Vandenberk, Bert},
title = {Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis},
journal = {European Journal of Heart Failure},
year = {2024},
volume = {26},
number = {2},
pages = {511--520},
doi = {10.1002/ejhf.3073}
}
EUVIMED